Lumos Pharma, Inc.
🏢 View company profile →9Patents
9Active
9Granted
47Portfolio score
Filing activity: Sep 1, 2015 → Apr 1, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10105352B2 | Detecting and treating growth hormone deficiency | Physics | 3 | Active |
| US10898472B2 | Detecting and treating growth hormone deficiency | Physics | 3 | Active |
| US11969416B1 | Compactable oral formulations of ibutamoren | Human Necessities | 1 | Active |
| US10377721B2 | Synthesis of cyclocreatine and analogs thereof | Chemistry; Metallurgy | 0 | Active |
| US10081605B2 | Synthesis of cyclocreatine and analogs thereof | Chemistry; Metallurgy | 0 | Active |
| US11234969B2 | Detecting and treating growth hormone deficiency | Physics | 0 | Active |
| US11485705B2 | Salts and prodrugs of 1-methyl-d-tryptophan | Chemistry; Metallurgy | 0 | Active |
| US10493062B2 | Synthesis of cyclocreatine and analogs thereof | Chemistry; Metallurgy | 0 | Active |
| US12390452B2 | Compactable oral formulations of ibutamoren | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.